Anthrax Research Today is a free monthly online journal that collates and summarizes the latest research about Anthrax, including details on bacillus anthracis, contagiousness, exposure, effects.

Volume 2 (2006), Issue 2 (February)

1. Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen.
   J Infect Dis, 193(5): 625-33. [Abstract] [Full-text]
2. The dltABCD operon of Bacillus anthracis sterne is required for virulence and resistance to peptide, enzymatic, and cellular mediators of innate immunity.
   J Bacteriol, 188(4): 1301-9. [Abstract] [Full-text]
3. Strategy for identification of Bacillus cereus and Bacillus thuringiensis strains closely related to Bacillus anthracis.
   Appl Environ Microbiol, 72(2): 1295-301. [Abstract] [Full-text]
4. Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors.
   Bioorg Med Chem Lett, 16(6): 1527-31. [Abstract] [Full-text]
5. Evidence for adjuvanticity of anthrax edema toxin.
   Vaccine, 24(6): 699-702. [Abstract] [Full-text]
6. Neutralizing antibodies and persistence of immunity following anthrax vaccination.
   Clin Vaccine Immunol, 13(2): 208-13. [Abstract] [Full-text]
7. Evaluating spatial surveillance: detection of known outbreaks in real data.
   Stat Med, 25(5): 755-69. [Abstract] [Full-text]
8. A workflow spatial scan statistic.
   Stat Med, 25(5): 743-54. [Abstract] [Full-text]
9. Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells.
   Biochemistry, 45(7): 2387-97. [Abstract] [Full-text]
10. Assembly and disassembly kinetics of anthrax toxin complexes.
    Biochemistry, 45(7): 2380-6. [Abstract] [Full-text]
11. The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.
    Biochem Biophys Res Commun, 341(4): 1164-71. [Abstract] [Full-text]
12. Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles.
    Pharm Res, 23(2): 262-9. [Abstract] [Full-text]
13. Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival.
    J Infect Dis, 193(6): 829-40. [Abstract] [Full-text]
14. A cluster of anthrax cases including meningitis.
    Trop Doct, 36(1): 51-3. [Abstract] [Full-text]
15. Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy.
    J Biol Chem, 281(8): 4831-43. [Abstract] [Full-text]
16. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.
    Vaccine, 24(10): 1501-14. [Abstract] [Full-text]
17. Acute lung infections in normal and immunocompromised hosts.
    Radiol Clin North Am, 44(2): 295-315, ix. [Abstract] [Full-text]
18. Anthrax lethal factor (LF) mediated block of the anthrax protective antigen (PA) ion channel: effect of ionic strength and voltage.
    Biochemistry, 45(9): 3060-8. [Abstract] [Full-text]
19. A simple, valveless microfluidic sample preparation device for extraction and amplification of DNA from nanoliter-volume samples.
    Anal Chem, 78(5): 1444-51. [Abstract] [Full-text]
20. Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.
    Vaccine, 24(14): 2530-6. [Abstract] [Full-text]

© 2005-2008 Anthrax Research Today. All Rights Reserved.